Interestingly, a recent study revealed that a combination of bis (α-furancarboxylato) oxovanadium and metformin ameliorates hepatic steatosis in high-fat diet-induced obese mice by alleviating hepatic inflammation and enhancing the insulin signaling pathway [45]. Here, INS is linked to Hepatic steatosis.